Vértigo y calidad de vida

Algunas veces el vértigo es una condición crónica

Referencias:

1. Della Pepa, C., Guidetti, G., & Eandi, M. (2006). Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otorhinolaryngologica Italica, 26(4), 208-215
2. Casani AP, Navari E, Guidetti G, Lacour M. Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière’s Disease. Int J Otolaryngol. 2018 Oct 25;2018:5359208. doi: 10.1155/2018/5359208. eCollection 2018.
3. Bradoo RA, et al. Management of Acute Vertigo with betahistine. Indian I of Otorlaryngology and head and Neck Surgery 2000; 52(2): 151-158.
4. Lacour M, et al. Betahistine in the treatment of Ménière’s Disease. neuro Dis Treat 2007; (3): 429-440.
5. Guerra J, Devesa J. Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors. Journal of Otology. 2020; 15 : 155-160.
6. Guerra J, Devesa J. Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors. Journal of Otology. 2020; 15 : 155-160
7. Sfakianaki I, et al. Risk Factors for Recurrence of Benign Paroxysmal PositionalVertigo. A Clinical Review. J. Clin. Med. 2021, 10, 4372.
8. Murdin L, et al. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev. 2016 Jun 21;2016(6):CD010696